Prevention of heart disease by subcutaneous desferrioxamine in patients with thalassaemia major.
Richardson, M E
Prevention of heart disease by subcutaneous desferrioxamine in patients with thalassaemia major. [electronic resource] - Australian and New Zealand journal of medicine Dec 1993 - 656-61 p. digital
Publication Type: Journal Article
0004-8291
10.1111/j.1445-5994.1993.tb04722.x doi
Adolescent
Adult
Cardiomyopathies--diagnosis
Child
Deferoxamine--administration & dosage
Electrocardiography
Female
Ferritins--blood
Humans
Infusion Pumps
Iron--metabolism
Liver--metabolism
Male
Patient Compliance
Retrospective Studies
Risk Factors
Siderosis--etiology
Transfusion Reaction
beta-Thalassemia--complications
Prevention of heart disease by subcutaneous desferrioxamine in patients with thalassaemia major. [electronic resource] - Australian and New Zealand journal of medicine Dec 1993 - 656-61 p. digital
Publication Type: Journal Article
0004-8291
10.1111/j.1445-5994.1993.tb04722.x doi
Adolescent
Adult
Cardiomyopathies--diagnosis
Child
Deferoxamine--administration & dosage
Electrocardiography
Female
Ferritins--blood
Humans
Infusion Pumps
Iron--metabolism
Liver--metabolism
Male
Patient Compliance
Retrospective Studies
Risk Factors
Siderosis--etiology
Transfusion Reaction
beta-Thalassemia--complications